Jazz Pharmaceuticals jazzpharma.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146) Neuroscience Startups (942)

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing products to meet unmet medical needs in neurology and psychiatry. The company's goal is to build a broad portfolio of products through a combination of internal development and acquisition and in-licensing activities and to utilize specialty sales force to promote products in target markets. Jazz Pharmaceuticals applies formulations and drug delivery technologies to known drug compou...Show all

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing products to meet unmet medical needs in neurology and psychiatry. The company's goal is to build a broad portfolio of products through a...Show all

Company (IPO / Went public)

Phone: +353 1 634 7800

Fax:

Fourth Floor, Connaught House
One Burlington Road
Dublin, 4
Ireland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Jazz Pharmaceuticals $439M Jul 7, 2008
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Jazz Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Adams Street PartnersVenture CapitalChicago, Illinois, United StatesSeries B
EGS Healthcare Capital PartnersPrivate EquityNorwalk, Connecticut, United StatesSeries B
Kohlberg Kravis Roberts & Co.Private EquityNew York, New York, United StatesSeries B
Golden Gate CapitalPrivate EquitySan Francisco, California, United StatesSeries B
Beecken Petty O'Keefe & CompanyPrivate EquityChicago, Illinois, United StatesPIPE - II, Series B
See all 10 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pegylated l-asparaginase Aug 05, 2015 Mar 20, 2018 Patent
Devices and methods for facilitating and controlling use of a medication Sep 02, 2014 Oct 31, 2017 Patent
Immediate release formulations and dosage forms of gamma-hydroxybutyrate Jun 03, 2014 Oct 24, 2017 Patent
Method for administering ω-conopeptide Jun 30, 2015 Jul 18, 2017 Patent
Treatment for obesity Dec 01, 2015 May 16, 2017 Patent
See all 52 patents